US 10968261
Methods and compositions for genome engineering
granted A61KA61K48/00A61P
Quick answer
US patent 10968261 (Methods and compositions for genome engineering) held by Sangamo Therapeutics, Inc. expires Mon Apr 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sangamo Therapeutics, Inc.
- Grant date
- Tue Apr 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K48/00, A61P, A61P3/00, A61P43/00